What Researchers Did
Researchers conducted clinical trials to evaluate the use of hyperbaric oxygen in conjunction with radiotherapy for various cancers.
What They Found
The trials demonstrated improved local cure and survival rates in patients with head and neck and cervical cancers. Evidence also suggested benefit for carcinoma of the bronchus, though no benefit was observed for carcinoma of the bladder. Despite increased effects on normal tissues, hyperbaric oxygen appeared to offer a real improvement in the therapeutic ratio when combined with radiotherapy.
What This Means for Canadian Patients
For Canadian patients, these early findings suggested that hyperbaric oxygen could potentially enhance the effectiveness of radiotherapy for specific cancers like head and neck or cervical cancer. This research laid groundwork for exploring combination therapies to improve cancer treatment outcomes, though current practices may have evolved significantly since 1978.
Canadian Relevance
This study has no direct Canadian connection as it was conducted by the Medical Research Council's working party, likely in the UK.
Study Limitations
A key limitation is that the future utility of hyperbaric oxygen in radiotherapy was noted to depend on its comparative effectiveness against other emerging treatment methods.